PrEP, Female, Injectable Baseline + HIV RNA
Also known as: HIV, PrEP, Prophylaxis
Use
This profile aligns with current guidelines for assessment of female patients prior to the initiation of injectable HIV PrEP.
Special Instructions
This profile requires a dedicated, unopened, gel-barrier tube and 2 frozen (preferred) or refrigerated serum pour-off tubes. Clients must clearly label the site/source of each Chlamydia/Gonococcus Nucleic Acid Amplification specimen. Tests may exhibit interference when sample is collected from a person consuming a high dose of biotin. Patients should be cautioned to stop biotin consumption at least 72 hours prior to collection.
Limitations
HIV p24 antigen/antibody specimens with reactive results require further investigation through additional supplemental tests. A negative test does not preclude exposure to or infection with HIV-1 and/or HIV-2. Negative results may occur if the marker quantity in the sample is too low for detection or absent during disease stage collection.
Methodology
Other
Biomarkers
LOINC Codes
- 56888-1
- 25835-0
- 69353-1
- 55752-0
- 47236-5
- 43304-5
- 43305-2
- 11502-2
- 5196-1
- 22322-2
- 13952-7
- 77202-0
- 56850-1
- 13955-0
- 45194-8
Result Turnaround Time
2-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
11 mL
Minimum Volume
7 mL
Container
Gel-barrier tube
Collection Instructions
Usual blood collection technique. Transfer serum to a screw-cap polypropylene transport tube. Ship frozen (preferred) or refrigerated.
Storage Instructions
Refrigerate gel-barrier tubes up to 6 days. Ship PCR test frozen up to 6 weeks.
Causes for Rejection
Hemolysis; lipemia; improper storage or transport; expired transport device; incorrect specimen volume.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 30 days |
| Refrigerated | 6 days |
| Frozen | 6 weeks |